Pharmaceuticals

Tue, 07/27/2010 - 12:44

Kechuang Medicine to invest $44.25 mln in new TCM subsidiary

Shanghai. July 27. INTERFAX-CHINA - Sichuan Kechuang Medicine Group Co. Ltd. plans to invest RMB 300 million ($44.25 million) in a new traditional Chinese medicine (TCM) subsidiary based in Bazhong City, Sichuan Province, a local newspaper reported July 27.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW